These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 23224461)

  • 41. Complexities of Diagnosing Neuroleptic Malignant Syndrome in a Patient with Burn Injury: Could Stimulant Abuse be a Risk Factor?
    Laughon SL; Sowa NA; Gala GJ
    Psychosomatics; 2016; 57(5):534-9. PubMed ID: 27374755
    [No Abstract]   [Full Text] [Related]  

  • 42. [Olanzapine-associated neuroleptic malignant syndrome. A case report and favorable response to risperidone].
    López-Torres E; Cobo I; Lucena MI
    Actas Esp Psiquiatr; 2007; 35(2):145-6. PubMed ID: 17401786
    [No Abstract]   [Full Text] [Related]  

  • 43. Neuroleptic malignant syndrome, poor science and inaccurate measurements.
    Gillman PK
    J Psychopharmacol; 2011 Jun; 25(6):850. PubMed ID: 20488833
    [No Abstract]   [Full Text] [Related]  

  • 44. Neuroleptic malignant syndrome associated with olanzapine.
    Johnson V; Bruxner G
    Aust N Z J Psychiatry; 1998 Dec; 32(6):884-6. PubMed ID: 10084355
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital.
    Pope HG; Keck PE; McElroy SL
    Am J Psychiatry; 1986 Oct; 143(10):1227-33. PubMed ID: 2876647
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Catatonia and neuroleptic malignant syndrome in a mentally retarded patient].
    Heikkilä J; Raitasuo S; Lauerma H; Mölsä P
    Duodecim; 1992; 108(12):1120-4. PubMed ID: 1366062
    [No Abstract]   [Full Text] [Related]  

  • 47. [Intensive care treatment for neuroleptic malignant syndrome].
    Hensel M; Böhler K; Marnitz R; Binder C; von Brevern M
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2010 Jul; 45(7-8):448-55. PubMed ID: 20665353
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neuroleptic Malignant syndrome (NMS): a rare presentation induced by an antiemetic - case report.
    Kashyap GL; Patel AG
    Psychiatr Danub; 2011 Sep; 23 Suppl 1():S43-5. PubMed ID: 21894101
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neuroleptic malignant syndrome with the addition of aripiprazole to olanzapine.
    Marshall PB; Mellman TA; Nguyen SX
    Am J Psychiatry; 2008 Nov; 165(11):1488-9. PubMed ID: 18981078
    [No Abstract]   [Full Text] [Related]  

  • 50. Pisa syndrome caused by an acetylcholinesterase inhibitor in a patient with dementia with Lewy bodies.
    Shinfuku M; Nakajima S; Uchida H; Watanabe K; Kocha H; Kashima H
    Psychiatry Clin Neurosci; 2011 Apr; 65(3):299. PubMed ID: 21507139
    [No Abstract]   [Full Text] [Related]  

  • 51. Neuroleptic malignant syndrome in a patient with neurosyphilis.
    Cannon T; Sperry L
    Wis Med J; 1992 Sep; 91(9):530-2. PubMed ID: 1462647
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Catatonic syndrome and neuroleptic malignant syndrome].
    Ruzikowska A
    Psychiatr Pol; 1999; 33(3):415-25. PubMed ID: 10786241
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [What do we know today about neuroleptic malignant syndrome?].
    Nyquist OG
    Tidsskr Nor Laegeforen; 1996 Oct; 116(24):2879-82. PubMed ID: 8975402
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neuroleptic malignant syndrome presenting with acute renal failure.
    Duggal HS; Singh I
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):1074-5. PubMed ID: 18281139
    [No Abstract]   [Full Text] [Related]  

  • 55. Neuroleptic malignant syndrome and low-dose olanzapine.
    Suh H; Bronson B; Martin R
    Am J Psychiatry; 2003 Apr; 160(4):796. PubMed ID: 12668376
    [No Abstract]   [Full Text] [Related]  

  • 56. [Neuroleptic malignant syndrome--3 case reports].
    Simmich T; Müller J; Bach O
    Psychiatr Neurol Med Psychol (Leipz); 1990 Jun; 42(6):369-75. PubMed ID: 1976268
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Myocardial infarction: an unusual complication of neuroleptic malignant syndrome.
    Becker D; Birger M; Samuel E; Floru S
    J Nerv Ment Dis; 1988 Jun; 176(6):377-8. PubMed ID: 3373202
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Benign type of malignant syndrome.
    Lancet; 1989 Jan; 1(8628):49-50. PubMed ID: 2563034
    [No Abstract]   [Full Text] [Related]  

  • 59. [Neuroleptic malignant syndrome associated with the inadequate antidiuretic hormone secretion syndrome].
    García Escrig M; Bermejo Pareja F; Soto Téllez O; Díaz Guzmán J; Lledó A
    Arch Neurobiol (Madr); 1992; 55(2):75-8. PubMed ID: 1352098
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neuroleptic malignant syndrome in cycloserine-induced psychosis.
    Sawant NS; Kate NS; Bhatankar SS; Kulkarni PS
    Indian J Pharmacol; 2015; 47(3):328-9. PubMed ID: 26069374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.